13.12 USD
↘ 0.17 (1.28%)LIVE (AS OF 11:54 AM EST)
Shares of Trevi Therapeutics, Inc. Common Stock (TRVI) are trading at $13.12. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. TRVI is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 16, 2026.